Flotek Industries, Inc. ((FTK)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Flotek Industries’ latest earnings call struck an upbeat tone, as management highlighted record revenue, surging Data Analytics profitability, and strong upstream growth that more than offset a softer quarter in Chemistry and temporary tax-driven EPS pressure. Executives framed 2025 as an inflection year and laid out clear levers to extend this momentum into 2026.
Record Revenue and Historical Highs
Flotek reported its highest quarterly and annual revenues since 2017, underscoring a broad-based rebound across the portfolio. Total company revenue climbed 33% year over year in the fourth quarter, with the Data Analytics segment setting all-time quarterly and annual records that helped lift overall performance.
Data Analytics Explosive Growth and Profitability
Data Analytics service revenue soared, with management pointing to a roughly 381% increase versus the comparable period and a dramatic profitability shift. Segment gross margin reached 73% in Q4 2025 versus 39% a year earlier, and Data Analytics contributed 48% of total company gross profit in 2025, up sharply from just 8% a year ago.
Upstream Revenues and Margin Expansion
Upstream analytics emerged as a major growth engine, with revenue jumping from $2.1 million in 2024 to more than $21 million in 2025. Gross profit followed suit, rising from $1.2 million to $18.4 million, signalling strong margin expansion and validating the company’s push into higher-value upstream data services.
Adjusted EBITDA and Net Income Improvement
Profitability improved meaningfully, with adjusted EBITDA up 123% for the full year and about 40% higher in the quarter under the revised methodology. Management said full-year adjusted EBITDA landed near the top of its guidance range, while net income increased about 191% in 2025, reflecting leverage on rising revenues.
Recurring Revenue and Backlog Momentum
Flotek exited the year with more than $12.02 million per month in recurring, high-margin Data Analytics revenue, giving investors better visibility into future cash flows. A multiyear backlog further supports expectations for sustained margin expansion as deployments scale and contract terms mature.
PowerTech Integration and Revenue Catalyst
The company completed onboarding of PowerTech, which delivered $15.8 million of revenue in 2025 and is positioned as a key 2026 growth driver. Management expects PowerTech revenue to exceed $27 million next year, roughly a 70% increase, with additional upside from a utility and disaster recovery contract.
Technology and Measurement Milestone
Flotek’s XBEG spectrometer achieved a notable industry first by meeting GPA 2172 custody-transfer reproducibility and repeatability standards. This qualification unlocks valuable custody-transfer and digital valuation applications, giving the company a competitive edge in high-specification measurement markets.
Chemistry Segment Resilience
Despite a weaker quarter, the Chemistry Technology business showed resilience over the full year, with 2025 revenue up roughly 25% versus 2024 excluding a prior OSP payment. This growth came even as the average North American frac fleet count fell 24%, implying tangible market share gains in a tougher operating backdrop.
Safety and Operational Excellence
Operational execution remained a bright spot, as field operations recorded zero lost time incidents for the year, supporting reliability for customers. The Prescriptive Chemistry Management and Raceland NTI team extended a decade-long streak without a lost time incident, reinforcing the company’s safety culture.
Balance Sheet and Deferred Tax Recognition
Total assets climbed to just over $220 million after Flotek released a valuation allowance and recognized deferred tax assets. The company ended the year with $5.7 million in cash and $3.3 million drawn on its asset-based line, and management expects non-cash tax adjustments to normalize, reducing volatility in reported earnings.
Quarterly Chemistry Revenue Weakness
Not all trends were positive, as external customer Chemistry revenue fell about 30% year over year in the fourth quarter, largely tied to slower activity in November and December. Even so, full-year external Chemistry revenue still rose roughly 26% versus 2024, suggesting the Q4 dip was more cyclical than structural.
Quarterly Net Income and EPS Pressure
Fourth-quarter net income slipped to $3.0 million, or $0.08 per diluted share, from $4.4 million, or $0.14, in the prior-year quarter. Management cited higher depreciation and interest from the PowerTech acquisition, along with a temporary spike in the effective tax rate, as key drivers of the short-term EPS headwind.
Spike in Effective Tax Rate
The effective tax rate jumped to about 35% in Q4 from 7% a year earlier, reflecting non-cash changes linked to valuation allowance adjustments. Executives expect the rate to settle closer to roughly 21% going forward, with minimal cash taxes outside of state obligations, which should support future net income.
Increased SG&A and Non-Recurring Costs
Selling, general, and administrative expenses rose versus the prior-year quarter due to higher personnel costs, including stock-based pay, and elevated professional fees tied to integrated audits. However, SG&A as a share of revenue improved to 11% from 13%, indicating better operating efficiency despite higher absolute spending.
Product Mix and Penalty Impact on Margins
Gross margin in the fourth quarter came in at 22.5% of revenue, pressured by less favorable product mix and a shortfall penalty linked to a large ProFrac quarter. Management noted that this penalty reduced sequential gross profit by about $5 million, making it a notable but one-time drag on profitability.
International Supply-Chain and Geopolitical Risks
Management also flagged ongoing international risks, particularly shipping disruptions related to regional conflicts that have affected specialty chemical supply routes. These issues may increase shipping costs and require more expensive alternative logistics, although the company stressed that these challenges are being actively managed.
Forward-Looking Guidance and 2026 Outlook
Looking ahead, Flotek expects adjusted EBITDA, which grew 123% in 2025, to remain strong and noted it would be about $10.1 million under its prior calculation method. PowerTech revenue is projected to exceed $27 million in 2026, Data Analytics profitability is expected to surpass 50% of company earnings, CapEx should rise to roughly $10–$15 million to support fleet growth, and tax rates are anticipated to normalize around 21%.
Flotek’s earnings call painted a picture of a company shifting decisively toward high-margin, technology-driven revenue streams while managing short-term noise in Chemistry and taxes. For investors, the combination of booming Data Analytics, a ramping PowerTech platform, and rising recurring revenue offers a compelling growth story heading into 2026, albeit with some geopolitical and execution risks to monitor.

